(Q43881086)

27 November 2017

Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells (English)

1 reference

27 November 2017

Muscettola M

1

1 reference

PubMed ID

1975794

27 November 2017

Grasso G

series ordinal

2

1 reference

27 November 2017

1 June 1990

1 reference

27 November 2017

1 reference

27 November 2017

180

1 reference

27 November 2017

419-430

1 reference

27 November 2017

4-5

1 reference

Brain, behavior, and immunity

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Neuroimmune interactions: experimental and clinical strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

1 reference

7 January 2021

Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Influence of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of human peripheral blood T lymphocytes to mercuric chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

The role of vasoactive intestinal peptide and other neuropeptides in the regulation of the immune response in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Determination of human T cell activity in response to allogeneic cells and mitogens. An immunochemical assay for gamma-interferon is more sensitive and specific than a proliferation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

DNA synthesis and interferon release by human peripheral lymphocytes exposed to high potassium medium

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Cycle of VIP in the human transformed colonic epithelial cells (HT-29) in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Interaction of vasoactive intestinal peptide with human blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Immune interferon: a pleiotropic lymphokine with multiple effects

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Interferon and the cellular immune response: separation of interferon-producing cells from DNA-synthetic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Production of interferon in the murine mixed lymphocyte culture. II. Interferon production is a T cell-dependent function, independent of proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Interferon production by mitogen-stimulated human lymphocytes requires differentiation but not DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Vasoactive intestinal peptide as a modulator of lymphocyte and immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

HLA-DR-like antigens in the epithelium of the human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Expression of HLA-DR antigens on epithelium associated with lymphoid tissue in the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Induction of Various HLA Class II Molecules in a Human Colonic Adenocarcinoma Cell Line

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980303-7

7 January 2021

10.1016/S0171-2985(11)80303-7

Identifiers

DOI

0 references

Fatcat ID

release_wkaa5njyczdldnhsgcehhfqxri

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wkaa5njyczdldnhsgcehhfqxri

24 November 2022

mapped directly with Wikidata item

PubMed ID

1975794

1 reference

PubMed ID

1975794